NCT04379518 2026-01-13Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer PatientsRoswell Park Cancer InstitutePhase 1/2 Terminated4 enrolled 30 charts
NCT00038376 2018-10-29Phase II Study Of Roferon and Accutane For Patients With T-Cell MalignanciesM.D. Anderson Cancer CenterPhase 2 Completed56 enrolled